A.D. Watters

1.1k total citations
18 papers, 858 citations indexed

About

A.D. Watters is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.D. Watters has authored 18 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.D. Watters's work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (9 papers) and Renal cell carcinoma treatment (3 papers). A.D. Watters is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (9 papers) and Renal cell carcinoma treatment (3 papers). A.D. Watters collaborates with scholars based in United Kingdom, Finland and South Africa. A.D. Watters's co-authors include John M.S. Bartlett, James J. Going, Ken Grigor, Timothy G. Cooke, T Cooke, Mark A. Underwood, Jorma Isola, Minna Tanner, Amanda Forsyth and Elizabeth A. Mallon and has published in prestigious journals such as Clinical Cancer Research, The Journal of Urology and British Journal of Cancer.

In The Last Decade

A.D. Watters

17 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.D. Watters United Kingdom	12	530	414	318	227	173	18	858
WJ Gullick United Kingdom	8	847 1.6×	448 1.1×	461 1.4×	101 0.4×	211 1.2×	11	1.1k
Oliver Stoß Germany	10	532 1.0×	471 1.1×	254 0.8×	96 0.4×	138 0.8×	16	1.0k
Hedvika Novotny Switzerland	8	440 0.8×	307 0.7×	137 0.4×	74 0.3×	223 1.3×	12	703
M. Bennett United Kingdom	3	295 0.6×	218 0.5×	107 0.3×	129 0.6×	96 0.6×	5	590
Heidi Bissig Switzerland	8	386 0.7×	477 1.2×	76 0.2×	93 0.4×	188 1.1×	8	824
T Hirota Japan	12	399 0.8×	202 0.5×	143 0.4×	130 0.6×	166 1.0×	25	670
Daniela Kandioler-Eckersberger Austria	8	389 0.7×	220 0.5×	106 0.3×	63 0.3×	235 1.4×	11	583
Charles H. W. Horne United Kingdom	12	327 0.6×	201 0.5×	124 0.4×	67 0.3×	97 0.6×	24	613
JM Varley United Kingdom	9	545 1.0×	426 1.0×	148 0.5×	37 0.2×	221 1.3×	11	814
Quan Hong United States	13	676 1.3×	212 0.5×	134 0.4×	256 1.1×	97 0.6×	26	941

Countries citing papers authored by A.D. Watters

Since Specialization

Citations

This map shows the geographic impact of A.D. Watters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.D. Watters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.D. Watters more than expected).

Fields of papers citing papers by A.D. Watters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.D. Watters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.D. Watters. The network helps show where A.D. Watters may publish in the future.

Co-authorship network of co-authors of A.D. Watters

This figure shows the co-authorship network connecting the top 25 collaborators of A.D. Watters. A scholar is included among the top collaborators of A.D. Watters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.D. Watters. A.D. Watters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Isola, Jorma, Minna Tanner, Amanda Forsyth, et al.. (2004). Interlaboratory Comparison ofHER-2Oncogene Amplification as Detected by Chromogenic and Fluorescencein situHybridization. Clinical Cancer Research. 10(14). 4793–4798. 137 indexed citations

Watters, A.D., et al.. (2003). HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. British Journal of Cancer. 89(7). 1305–1309. 65 indexed citations

Watters, A.D., James J. Going, T Cooke, & John M.S. Bartlett. (2003). Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma. Breast Cancer Research and Treatment. 77(2). 109–114. 107 indexed citations

Watters, A.D., et al.. (2003). HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?. European Journal of Cancer. 40(1). 56–63. 97 indexed citations

Watters, A.D., Alec Forsyth, Ian F. Dunn, et al.. (2002). Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. British Journal of Cancer. 87(6). 654–658. 32 indexed citations

Edwards, Joanne, et al.. (2002). Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder. The Journal of Pathology. 196(4). 380–385. 25 indexed citations

Watters, A.D., Michael W. Stacey, & John M.S. Bartlett. (2002). A Modified Nick Translation Method Used with FISH that Produces Reliable Results with Archival Tissue Sections. Molecular Biotechnology. 20(3). 257–260.

Watters, A.D., James J. Going, Kenneth M. Grigor, & John M.S. Bartlett. (2002). Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours. European Journal of Cancer. 38(12). 1593–1599. 10 indexed citations

Watters, A.D. & John M.S. Bartlett. (2002). Fluorescence In Situ Hybridization in Paraffin Tissue Sections. Molecular Biotechnology. 21(3). 217–220. 9 indexed citations

10.

Watters, A.D., et al.. (2002). Gene amplification and overexpression of HER2 in renal cell carcinoma. British Journal of Urology. 89(1). 5–9. 29 indexed citations

11.

Bartlett, John M.S., James J. Going, Elizabeth A. Mallon, et al.. (2001). Evaluating HER2 amplification and overexpression in breast cancer. The Journal of Pathology. 195(4). 422–428. 195 indexed citations

12.

Edwards, Joanne, N. Sarath Krishna, R Mukherjee, et al.. (2001). Amplification of the androgen receptor may not explain the development of androgen‐independent prostate cancer. British Journal of Urology. 88(6). 633–637. 35 indexed citations

13.

Watters, A.D., Michael W. Stacey, James J. Going, et al.. (2001). Genetic Aberrations of <i>NAT2</i> and Chromosome 8: Their Association with Progression in Transitional Cell Carcinoma of the Urinary Bladder. Urologia Internationalis. 67(3). 235–239. 7 indexed citations

14.

Edwards, Joanne, et al.. (2001). Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder. British Journal of Cancer. 85(12). 1894–1899. 16 indexed citations

15.

Watters, A.D., S Ballantyne, James J. Going, Ken Grigor, & John M.S. Bartlett. (2000). Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. British Journal of Urology. 85(1). 42–47. 35 indexed citations

16.

Bartlett, J. M. S., A.D. Watters, S Ballantyne, et al.. (1999). Is Chromosome 9 Loss a Marker of Disease Recurrence in Transitional Cell Carcinoma of the Urinary Bladder?. The Journal of Urology. 161(2). 716–716. 7 indexed citations

17.

Bartlett, JMS, A.D. Watters, S Ballantyne, et al.. (1998). Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?. British Journal of Cancer. 77(12). 2193–2198. 46 indexed citations

18.

Elles, R, et al.. (1990). Recombination or heterogeneity: is there a second locus for adult polycystic kidney disease?. Journal of Medical Genetics. 27(7). 413–417. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact